The Outcomes of Living Donor Robotic Assisted Kidney Transplantation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorWest China Hospital
About this trial
The technology for robot-assisted kidney transplantation (RAKT) has become increasingly advanced, with numerous studies demonstrating comparable outcomes between RAKT surgery and open surgery. This advancement is particularly noteworthy as it extends its suitability to transplant patients with obesity. It will be important to explore the results of robot-assisted kidney transplantation as compared with open surgery or within cohorts.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
living-donor kidney transplant recipients
receiving standard triad immunosuppressive regimen
Disqualifiers
active infection
multi-organ transplantation
malignancy history in the donor and recipient
human immunodeficiency virus infection
Trial population
Patients with stage 5 chronic kidney disease undergoing living robot-assisted kidney transplantation
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
400 Participants
are grouped into 2 trial groupsGroup A: grafts with a single artery (GSA)
Group B: grafts with multiple single arteries (GMA)
Trial outcomes
Primary outcomes
1
The graft function of recipients
the graft function of recipients per month after transplant surgery, assessed by the serum creatinine (umol/L) and estimated glomerular function rate (eGFR).
Time frame
in the follow-up period，about six months to one yearSecondary outcomes
1
total operative time
The time from the beginning of the procedure to the end of the procedure (minute)
Time frame
about 150 minutes to 300 minutesSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov